CAS Medical awarded two new U.S renseignements de médication . Patents CAS Medical Systems offers announced that it has been awarded two United States Patents for technology used in its Fore-View Cerebral Oximeter, which is scheduled for commercial discharge in late 2006. The patents represent several years of study and development focused on bringing to market a non-invasive, commercially viable technology that allows clinicians to monitor complete levels of oxygen saturation in the mind. The new patents cover aspects of the FORE-SIGHT individual sensor design and laser safety system, as well as the algorithm method used by the FORE-SIGHT device to allow for a complete measurement. Our study and development team has made great strides in the advancement of this device, and the receipt of two even more patents for technology found in FORE-SIGHT is an important milestone and highlights our solid IP position, stated Louis P.